"Clinical microbiology market"
The clinical microbiology product includes laboratory instruments such as autoclaves, incubators, culture systems and modern automated systems such as gram strainers, culture filler, automated colony counters. The market also includes microbiological analyzers systems for investigation of specimens and samples. The microbiological analyzers segment includes molecular diagnostic kits, high-end and/or super-resolution microscopes and mass spectrometers for diagnosis and analysis.
The clinical application of the market helps in diagnosis of infectious diseases such as respiratory, urinary, bloodstream, sexually transmitted, gastrointestinal and periodontal diseases.
"Growth drivers of the clinical microbiology market:"
The larger disease burden of infectious diseases is driving the market. As per the World Health Organization (WHO) in 2012, 56 million people died worldwide out of which, 23% accounts for infectious diseases. This is due to growing industrialization leading to air pollution and other health hazards. Sudden out breaks of diseases such as Ebola, Zika and other contagious pathogens are some of the factors contributing to rising prevalence rate of infectious diseases.
With technology advancement the instruments and equipment used in laboratories are rapidly replacing manually operated units with automated devices. Automation has benefits such as time saving, use of less labors and space in laboratories. Thus, market is witnessing strong growth. Some of the market players are introducing advanced products in the market. E.g. in June 2015, bioMerieux S.A. launched VIRTUO blood culture system. It is an automated system that continuously monitors the blood culture for microbe detection. And many other major players introduced automated laboratory systems such as automated gram strainers and media fillers.
"Highly developed healthcare infrastructure and high adoption of advanced diagnostic techniques is spurring the demand for clinical microbiology in the U.S.:"
Highly developed healthcare sector in the U.S. is fueling the adoption of clinical microbial techniques in the country. In addition, well defined regulatory framework and presence of giant players in the country are supporting the growth in the U.S.
Asia Pacific is expected to be the fastest growing region over the forecast period. Japan is one of the leading countries with strong technological development and higher usage of microbial testing for various applications. In addition, China is also expected to share significantly in the adoption of automated laboratory systems over the forecast period to drive the growth of market.
Large market potential is attracting many players to the clinical microbiology market. In addition, existing players are investing heavily in research and development aiming introduction of technically advanced products in the market to remain competent. Some of themajor players operating in the market include but are not limited to biomerieux. S.A, Abbott Laboratories, Cepheid Inc., Bio Rad Laboratories. Inc., Hologic, Inc, Roche Diagnostics, AlereInc., Becton Dickinson & Company and Bruker Corporation.
In-depth report on global clinical microbiology market by Grand View Research: